8-K
Current Report
SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-010093
Executive or director change · Regulation FD disclosure
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading sabs-20240130.htm…